Drug Facts
Active ingredient(in each tablet)
Famotidine 20 mg
The following Structured Product Label (SPL) was submitted to the FDA by Leader/ Cardinal Health 110, Inc. for the product Famotidine (NDC 70000-0710). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding drug facts, otc - purpose, uses, warnings, otc - do not use, otc - ask doctor, otc - ask doctor/pharmacist, otc - stop use, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Active ingredient(in each tablet)
Famotidine 20 mg
Purpose
Acid reducer
Allergy alert: Do not use if you are allergic to famotidine or other acid reducers.
Do not use
Ask a doctor before use if you have
Ask a doctor or pharmacist before use if you are taking a prescription drug. Acid reducers may interact with certain prescription drugs.
Stop use and ask a doctor if
If pregnant or breast-feeding, ask a health professional before use.
Keep out of reach of children.
In case of overdose, get medical help or contact a Poison Control Center right away. (1-800-222-1222).
colloidal silicon dioxide, hypromellose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, pregelatinized starch, sodium starch glycolate, talc, titanium dioxide.
Questions or comments?
1-800-231-4670:
weekdays 9am-5pm EST
DISTRIBUTED BY CARDINAL HEALTH
DUBLIN, OHIO 43017
www.myleader.com 1-800-200-6313
*This product is not manufactured or distributed by Kenvue Inc., owner of the registered trademark Pepcid AC®.
KEEP OUTER PACKAGE FOR COMPLETE PRODUCT INFORMATION
TAMPER EVIDENT: DO NOT USE IF IMPRINTED SAFETY SEAL UNDER CAP IS BROKEN OR MISSING
NDC 70000-0710-1
Maximum Strength
Acid Reducer
Famotidine Tablets USP, 20 mg
Just One Tablet Prevents
& Relieves Heartburn Due
to Acid Indigestion
COMPARE TO MAXIMUM STRENGTH PEPCID AC® active ingredient*
200
TABLETS
* Please review the disclaimer below.